Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 51

1.

Daily home hemodialysis: balancing cardiovascular benefits with infectious harms.

Nadeau-Fredette AC, Badve SV, Johnson DW.

Am J Kidney Dis. 2015 Jan;65(1):6-8. doi: 10.1053/j.ajkd.2014.08.012. No abstract available.

PMID:
25523799
2.

The association between body mass index and mortality in incident dialysis patients.

Badve SV, Paul SK, Klein K, Clayton PA, Hawley CM, Brown FG, Boudville N, Polkinghorne KR, McDonald SP, Johnson DW.

PLoS One. 2014 Dec 16;9(12):e114897. doi: 10.1371/journal.pone.0114897. eCollection 2014.

3.

The rationale and design of the Beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) Feasibility Study.

Roberts MA, Pilmore HL, Ierino FL, Badve SV, Cass A, Garg AX, Hawley CM, Isbel NM, Krum H, Pascoe EM, Tonkin AM, Vergara LA, Perkovic V; BLOCADE Study Collaborative Group.

Nephrology (Carlton). 2015 Mar;20(3):140-7. doi: 10.1111/nep.12362.

PMID:
25382452
4.

A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the Handling Erythropoietin Resistance With Oxpentifylline (HERO) trial.

Johnson DW, Pascoe EM, Badve SV, Dalziel K, Cass A, Clarke P, Ferrari P, McDonald SP, Morrish AT, Pedagogos E, Perkovic V, Reidlinger D, Scaria A, Walker R, Vergara LA, Hawley CM; HERO Study Collaborative Group.

Am J Kidney Dis. 2015 Jan;65(1):49-57. doi: 10.1053/j.ajkd.2014.06.020. Epub 2014 Aug 10.

PMID:
25115616
5.

End-stage kidney disease due to Alport syndrome: outcomes in 296 consecutive Australia and New Zealand Dialysis and Transplant Registry cases.

Mallett A, Tang W, Clayton PA, Stevenson S, McDonald SP, Hawley CM, Badve SV, Boudville N, Brown FG, Campbell SB, Johnson DW.

Nephrol Dial Transplant. 2014 Dec;29(12):2277-86. doi: 10.1093/ndt/gfu254. Epub 2014 Jul 24.

PMID:
25061124
6.

A nephrology guide to reading and using systematic reviews of randomized trials.

Badve SV, Palmer SC, Johnson DW, Strippoli GF.

Nephrol Dial Transplant. 2015 Jun;30(6):878-884. Epub 2014 Jun 23. Review.

7.

Biocompatible dialysis fluids for peritoneal dialysis.

Cho Y, Johnson DW, Craig JC, Strippoli GF, Badve SV, Wiggins KJ.

Cochrane Database Syst Rev. 2014 Mar 27;3:CD007554. doi: 10.1002/14651858.CD007554.pub2. Review.

PMID:
24671928
8.

The association between peritoneal dialysis modality and peritonitis.

Lan PG, Johnson DW, McDonald SP, Boudville N, Borlace M, Badve SV, Sud K, Clayton PA.

Clin J Am Soc Nephrol. 2014 Jun 6;9(6):1091-7. doi: 10.2215/CJN.09730913. Epub 2014 Mar 13.

PMID:
24626434
9.

Peritoneal dialysis outcomes after temporary haemodialysis transfer for peritonitis.

Cho Y, Badve SV, Hawley CM, McDonald SP, Brown FG, Boudville N, Clayton P, Johnson DW.

Nephrol Dial Transplant. 2014 Oct;29(10):1940-7. doi: 10.1093/ndt/gfu050. Epub 2014 Mar 3.

PMID:
24596083
10.

The Role of Monitoring Vancomycin Levels in Patients with Peritoneal Dialysis-Associated Peritonitis.

Stevenson S, Tang W, Cho Y, Mudge DW, Hawley CM, Badve SV, Johnson DW.

Perit Dial Int. 2015 3-4;35(2):222-228. Epub 2014 Mar 1.

PMID:
24584597
11.

SOCIO-ECONOMIC STATUS AND PERITONITIS IN AUSTRALIAN NON-INDIGENOUS PERITONEAL DIALYSIS PATIENTS.

Tang W, Grace BS, McDonald SP, Hawley CM, Badve SV, Boudville N, Brown FG, Clayton PA, Johnson DW.

Perit Dial Int. 2014 Feb 4. [Epub ahead of print]

PMID:
24497587
12.

Chronic kidney disease: haemodialysis catheter care in practice.

Badve SV, Johnson DW.

Nat Rev Nephrol. 2014 Mar;10(3):131-3. doi: 10.1038/nrneph.2014.3. Epub 2014 Jan 21. Review.

PMID:
24445741
13.

The role of monitoring gentamicin levels in patients with gram-negative peritoneal dialysis-associated peritonitis.

Tang W, Cho Y, Hawley CM, Badve SV, Johnson DW.

Perit Dial Int. 2014 Mar-Apr;34(2):219-26. doi: 10.3747/pdi.2012.00318. Epub 2014 Jan 2.

14.

Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): a randomised trial.

Johnson DW, Badve SV, Pascoe EM, Beller E, Cass A, Clark C, de Zoysa J, Isbel NM, McTaggart S, Morrish AT, Playford EG, Scaria A, Snelling P, Vergara LA, Hawley CM; HONEYPOT Study Collaborative Group.

Lancet Infect Dis. 2014 Jan;14(1):23-30. doi: 10.1016/S1473-3099(13)70258-5. Epub 2013 Oct 10.

PMID:
24119840
15.

Establishing a clinical trials network in nephrology: experience of the Australasian Kidney Trials Network.

Morrish AT, Hawley CM, Johnson DW, Badve SV, Perkovic V, Reidlinger DM, Cass A.

Kidney Int. 2014 Jan;85(1):23-30. doi: 10.1038/ki.2013.391. Epub 2013 Oct 2.

16.

Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis.

Bose B, Badve SV, Hiremath SS, Boudville N, Brown FG, Cass A, de Zoysa JR, Fassett RG, Faull R, Harris DC, Hawley CM, Kanellis J, Palmer SC, Perkovic V, Pascoe EM, Rangan GK, Walker RJ, Walters G, Johnson DW.

Nephrol Dial Transplant. 2014 Feb;29(2):406-13. doi: 10.1093/ndt/gft378. Epub 2013 Sep 15. Review.

PMID:
24042021
17.

Interventions for erythropoietin-resistant anaemia in dialysis patients.

Badve SV, Beller EM, Cass A, Francis DP, Hawley C, Macdougall IC, Perkovic V, Johnson DW.

Cochrane Database Syst Rev. 2013 Aug 26;8:CD006861. doi: 10.1002/14651858.CD006861.pub3. Review.

PMID:
23979995
18.

Association of biocompatible peritoneal dialysis solutions with peritonitis risk, treatment, and outcomes.

Cho Y, Badve SV, Hawley CM, McDonald SP, Brown FG, Boudville N, Bannister KM, Clayton PA, Johnson DW.

Clin J Am Soc Nephrol. 2013 Sep;8(9):1556-63. doi: 10.2215/CJN.12361212. Epub 2013 Aug 15.

19.

The HONEYPOT randomized controlled trial statistical analysis plan.

Pascoe EM, Lo S, Scaria A, Badve SV, Beller EM, Cass A, Hawley CM, Johnson DW.

Perit Dial Int. 2013 Jul-Aug;33(4):426-35. doi: 10.3747/pdi.2012.00310.

20.

The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients.

Cho Y, Johnson DW, Badve SV, Craig JC, Strippoli GF, Wiggins KJ.

Kidney Int. 2013 Nov;84(5):969-79. doi: 10.1038/ki.2013.190. Epub 2013 May 22. Review.

PMID:
23698236
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk